A detailed history of Invesco Ltd. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Invesco Ltd. holds 64,692 shares of BEAM stock, worth $1.72 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
64,692
Previous 65,369 1.04%
Holding current value
$1.72 Million
Previous $2.16 Million 29.83%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$21.22 - $32.66 $14,365 - $22,110
-677 Reduced 1.04%
64,692 $1.52 Million
Q1 2024

May 14, 2024

BUY
$23.46 - $45.07 $403,699 - $775,564
17,208 Added 35.73%
65,369 $2.16 Million
Q4 2023

Feb 12, 2024

SELL
$17.69 - $30.76 $33,080 - $57,521
-1,870 Reduced 3.74%
48,161 $1.31 Million
Q3 2023

Nov 13, 2023

SELL
$23.01 - $32.46 $7,915 - $11,166
-344 Reduced 0.68%
50,031 $1.2 Million
Q2 2023

Aug 11, 2023

SELL
$29.32 - $35.99 $8,268 - $10,149
-282 Reduced 0.56%
50,375 $1.61 Million
Q1 2023

May 12, 2023

BUY
$30.15 - $48.79 $533,232 - $862,899
17,686 Added 53.64%
50,657 $1.55 Million
Q4 2022

Feb 13, 2023

BUY
$36.73 - $51.6 $154,963 - $217,700
4,219 Added 14.67%
32,971 $1.29 Million
Q3 2022

Nov 14, 2022

BUY
$39.79 - $70.31 $136,917 - $241,936
3,441 Added 13.59%
28,752 $1.37 Million
Q2 2022

Aug 15, 2022

BUY
$29.86 - $62.36 $89,699 - $187,329
3,004 Added 13.47%
25,311 $980,000
Q1 2022

May 16, 2022

BUY
$53.73 - $82.16 $14,883 - $22,758
277 Added 1.26%
22,307 $1.28 Million
Q4 2021

Feb 14, 2022

SELL
$68.02 - $99.06 $88,766 - $129,273
-1,305 Reduced 5.59%
22,030 $1.76 Million
Q3 2021

Nov 15, 2021

BUY
$84.37 - $133.6 $358,825 - $568,200
4,253 Added 22.29%
23,335 $2.03 Million
Q2 2021

Aug 17, 2021

BUY
$64.12 - $128.71 $568,359 - $1.14 Million
8,864 Added 86.75%
19,082 $2.46 Million
Q1 2021

May 17, 2021

SELL
$71.28 - $120.75 $12.3 Million - $20.8 Million
-172,402 Reduced 94.4%
10,218 $818,000
Q4 2020

Feb 16, 2021

BUY
$22.24 - $95.63 $4.06 Million - $17.5 Million
182,620 New
182,620 $14.9 Million

Others Institutions Holding BEAM

About Beam Therapeutics Inc.


  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.87B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.